In addition, Sandeep et al. demonstrated that piperlongumine inhibits the proliferation of colon cancer cells by targeting Ras proteins and the PI3K/Akt signaling cascade, exhibiting marked anticancer properties (90). Here, AKT1 is linked to colonic neoplasm.